Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Neoplasm Metastasis 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

Paclitaxel 11Fluorouracil 10pembrolizumab 9Cisplatin 9Radiotherapy 7Carboplatin 6Esophagectomy 5Nivolumab 4Drug Therapy 4Radiotherapy, Intensity-Modulated 3Leucovorin 3Chemoradiotherapy 3Cetuximab 3Capecitabine 3durvalumab 2atezolizumab 2Oxaliplatin 2Ipilimumab 2spartalizumab 1sintilimab 1selinexor 1regorafenib 1prexasertib 1osimertinib 1niraparib 1nilotinib 1nedaplatin 1nanocis 1fludarabine 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × prexasertib × Gastrointestinal × Clear all
NCT01115790 2016-05-10

A Phase 1 Study in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed
150 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡